Cetuximab response in CRC patient-derived xenografts seems predicted by an expression based RAS pathway signature

出版年份 2016 全文链接

标题

作者

关键词

PDX, Erbitux, expression signature, patient stratification, biomarker

出版物

Volume 7, Issue 31, Pages -

出版商

Impact Journals, LLC

发表日期

2016-07-09

DOI

10.18632/oncotarget.10499

联系作者

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now